Key features and details
- Mouse monoclonal [MYH11/923] to smooth muscle Myosin heavy chain I
- Suitable for: IHC-P
- Reacts with: Rat, Human
- Isotype: IgG1
Product nameAnti-smooth muscle Myosin heavy chain I antibody [MYH11/923]
See all smooth muscle Myosin heavy chain I primary antibodies
DescriptionMouse monoclonal [MYH11/923] to smooth muscle Myosin heavy chain I
Tested applicationsSuitable for: IHC-Pmore details
Species reactivityReacts with: Rat, Human
Recombinant full length protein corresponding to Human smooth muscle Myosin heavy chain I.
Database link: P35749
- IHC-P: Human breast carcinoma, leiomyosarcoma, colon carcinoma and angiosarcoma tissue.
Reproducibility is key to advancing scientific discovery and accelerating scientists’ next breakthrough.
Abcam is leading the way with our range of recombinant antibodies, knockout-validated antibodies and knockout cell lines, all of which support improved reproducibility.
We are also planning to innovate the way in which we present recommended applications and species on our product datasheets, so that only applications & species that have been tested in our own labs, our suppliers or by selected trusted collaborators are covered by our Abpromise™ guarantee.
In preparation for this, we have started to update the applications & species that this product is Abpromise guaranteed for.
We are also updating the applications & species that this product has been “predicted to work with,” however this information is not covered by our Abpromise guarantee.
Applications & species from publications and Abreviews that have not been tested in our own labs or in those of our suppliers are not covered by the Abpromise guarantee.
Please check that this product meets your needs before purchasing. If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, as well as customer reviews and Q&As.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.05% Sodium azide
Constituents: PBS, 0.05% BSA
Concentration information loading...
PurityProtein A/G purified
Purification notesPurified from Bioreactor Concentrate by Protein A/G.
Light chain typekappa
Our Abpromise guarantee covers the use of ab233940 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||Use a concentration of 0.5 - 1 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Incubate with primary antibody for 30 minutes at room temperature.
RelevanceMYH11 is a smooth muscle myosin belonging to the myosin heavy chain family. It is a subunit of a hexameric protein that consists of two heavy chain subunits and two pairs of non-identical light chain subunits. It functions as a major contractile protein, converting chemical energy into mechanical energy through the hydrolysis of ATP.
- FAA4 antibody
- MYH11 antibody
- Myosin 11 antibody
Formalin-fixed, paraffin-embedded human breast carcinoma tissue stained for smooth muscle Myosin heavy chain I using ab233940 at 1 µg/ml in immunohistochemical analysis.
Formalin-fixed, paraffin-embedded human leiomyosarcoma tissue stained for smooth muscle Myosin heavy chain I using ab233940 at 1 µg/ml in immunohistochemical analysis.
Formalin-fixed, paraffin-embedded human colon carcinoma tissue stained for smooth muscle Myosin heavy chain I using ab233940 at 1 µg/ml in immunohistochemical analysis.
Formalin-fixed, paraffin-embedded human angiosarcoma tissue stained for smooth muscle Myosin heavy chain I using ab233940 at 1 µg/ml in immunohistochemical analysis.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab233940 has not yet been referenced specifically in any publications.